MIRONID LIMITED

Active Glasgow

Research and experimental development on biotechnology

16 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
M

MIRONID LIMITED

Research and experimental development on biotechnology

Founded 29 Apr 2014 Active Glasgow, Scotland 16 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 17 Jul 2025 Next due 30 Nov 2026 7 months remaining
Confirmation Submitted 25 Sept 2025 Next due 4 Oct 2026 5 months remaining
Net assets £-12M £7M 2024 year on year
Total assets £4M £6M 2024 year on year
Total Liabilities £16M £1M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Arbuthnott Building (Hamnett Wing) 161 Cathedral Street Glasgow G4 0RE Scotland

Email

info@example.com

Website

www.example.com

Full company profile for MIRONID LIMITED (SC476430), an active life sciences and medical technology company based in Glasgow, Scotland. Incorporated 29 Apr 2014. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2015–2024)

Cash in Bank

£2.30M

Decreased by £5.44M (-70%)

Net Assets

-£12.12M

Decreased by £7.00M (-137%)

Total Liabilities

£16.14M

Increased by £1.27M (+9%)

Turnover

N/A

Employees

16

Increased by 1 (+7%)

Debt Ratio

402%

Increased by 249 (+163%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 3
Grants 1

Investors (8)

Investor NameInvestor SinceParticipating Rounds
Investor 1Jun 2016Series A
Investor 2Jun 2016Series A
Investor 3Jun 2016Series A

Share Capital

Share Capital

Share allotments and capital structure

15 Allotments 835,368 Shares £20.96m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
21 Aug 202316,726£1.673£0
31 Mar 2023353,368£8.18m£23.144
30 Apr 20216,370£0.637£0
4 Feb 202158,762£1.70m£28.93
22 Jul 202058,762£1.70m£28.93

Officers

Officers

1 active 2 resigned
Status
Elaine Verne JonesDirectorAmericanUnited States7128 Aug 2019Active

Shareholders

Shareholders (21)

Epidarex Capital Ii, Lp
38.0%
Scottish Enterprise Glasgow
22.0%

Persons with Significant Control

Persons with Significant Control (0)

0 Active 1 Ceased

Epidarex Capital Ii, L.p.

Ceased 18 Dec 2019

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
22 Apr 2026CapitalAllotment of shares (GBP 188.208) on 1 Apr 2026
13 Apr 2026IncorporationMemorandum Articles
10 Apr 2026ResolutionResolutions
10 Apr 2026ResolutionResolutions
26 Feb 2026CapitalCapital Name Of Class Of Shares
22 Apr 2026 Capital

Allotment of shares (GBP 188.208) on 1 Apr 2026

13 Apr 2026 Incorporation

Memorandum Articles

10 Apr 2026 Resolution

Resolutions

10 Apr 2026 Resolution

Resolutions

26 Feb 2026 Capital

Capital Name Of Class Of Shares

Recent Activity

Latest Activity

Allotment of shares (GBP 188.208) on 1 Apr 2026

1 weeks ago on 22 Apr 2026

Memorandum Articles

2 weeks ago on 13 Apr 2026

Resolutions

3 weeks ago on 10 Apr 2026

Resolutions

3 weeks ago on 10 Apr 2026

Capital Name Of Class Of Shares

2 months ago on 26 Feb 2026